Ivan Surya Pradipta (1983) was born in Yogyakarta, Indonesia. After finishing high school in Bandar Lampung, Indonesia, he began studying pharmacy at the Faculty of Pharmacy, Universitas Padjadjaran, Indonesia in 2001. He finished his bachelor’s degree in Pharmacy, then continued his professional degree as a Pharmacist at the same University in 2006. He holds a master's degree in clinical pharmacy with cum-laude from the Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia, in 2009. After that, He continued working as a faculty member at the Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia. As a researcher, he has an interest in the topic of antimicrobial use and resistance. In February 2016, He started a Ph.D. trajectory at the Unit of Pharmaco-Therapy, -Epidemiology and -Economics (PTE2), University of Groningen, the Netherlands. His Ph.D. project focused on the strategy to improve treatment outcomes and control the drug resistance of tuberculosis. He actively presented his study at international conferences and successfully published his studies in the top 10% of scientific journals. Currently, He continues his academic career as a researcher at the Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia.
Ivan Surya Pradipta (1983) was born in Yogyakarta, Indonesia. After finishing high school in Bandar Lampung, Indonesia, he began studying pharmacy at the Faculty of Pharmacy, Universitas Padjadjaran, Indonesia in 2001. He finished his bachelor’s degree in Pharmacy, then continued his professional degree as a Pharmacist at the same University in 2006. He holds a master's degree in clinical pharmacy with cum-laude from the Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia, in 2009. After that, He continued working as a faculty member at the Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia. As a researcher, he has an interest in the topic of antimicrobial use and resistance. In February 2016, He started a Ph.D. trajectory at the Unit of Pharmaco-Therapy, -Epidemiology and -Economics (PTE2), University of Groningen, the Netherlands. His Ph.D. project focused on the strategy to improve treatment outcomes and control the drug resistance of tuberculosis. He actively presented his study at international conferences and successfully published his studies in the top 10% of scientific journals. Currently, He continues his academic career as a researcher at the Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia.